Engineering mechanotherapies
Mechanobiology · 2026-08 · 1
DOI: 10.1177/29780241261479992 ↗Kurz gefasst
Fachartikel in der Zeitschrift Mechanobiology, online erschienen am 21.08.2026. Verfasst von Jae-Won Shin. Die Arbeit nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Institute of General Medical Sciences, Division of Chemical, Bioengineering, Environmental and Transport Systems, National Heart, Lung, and Blood Institute.
Abstract (Originalsprache)
Mechanical forces are fundamental regulators of cellular behavior, shaping stem cell fate, immune responses, tissue repair, fibrosis, and tumor progression. Advances in mechanobiology and mechanomedicine have enabled engineered mechanotherapy: the deliberate and programmable manipulation of mechanical information to restore or modulate tissue function. Mechanotherapy encompasses interventions in which a specified mechanical input, alteration of tissue mechanical properties, or modulation of cellular mechanosensing serves as the therapeutic mechanism. Current approaches include biomaterial-based microenvironments, external force-delivery devices, remodeling of endogenous tissue mechanics, molecular targeting of mechanosensitive pathways, and emerging mechanogenetic systems. Preclinical studies demonstrate that these strategies can enhance regeneration, modulate immunity, alter pathological tissue mechanics, and relieve solid stress and interstitial hypertension in tumors to improve vascular perfusion, drug penetration, and immune cell infiltration. Major challenges remain in defining mechanical dose, achieving spatial and cellular specificity, and translating controlled experimental paradigms into clinically relevant applications. Establishing standardized metrics, predictive computational models, and mechanotransduction biomarkers will be essential for reproducibility and translation. By defining quantitative principles and design frameworks, engineered mechanotherapy can emerge as a clinically actionable modality that complements chemical and genetic therapies while harnessing the intrinsic language of mechanical information in biology.
Förderung
- National Institute of General Medical Sciences
- Division of Chemical, Bioengineering, Environmental and Transport Systems
- National Heart, Lung, and Blood Institute
- National Institute of Biomedical Imaging and Bioengineering
Zitieren
APA
Shin, J. (2026). Engineering mechanotherapies. Mechanobiology, 1. https://doi.org/10.1177/29780241261479992
Vancouver
Shin J. Engineering mechanotherapies. Mechanobiology. 2026;1. doi:10.1177/29780241261479992
BibTeX
@article{Shin2026,
author = {Shin, Jae-Won},
title = {Engineering mechanotherapies},
journal = {Mechanobiology},
year = {2026},
volume = {1},
doi = {10.1177/29780241261479992}
}
EUVIMED